Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Microbiotix Inc.
DescriptionPotent nucleoside DNA polymerase inhibitor
Molecular Target
Mechanism of ActionDNA polymerase inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationCytomegalovirus (CMV)
Indication DetailsTreat cytomegalovirus (CMV)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today